The global automated external defibrillators market size was valued at USD 1.93 Bn in 2022 and is likely to reach USD 3.91 Bn by 2031, expanding at a CAGR of 9.35% during 2023 – 2031. Increasing demand for portable and lightweight defibrillator devices to restore a normal heartbeat during a sudden cardiac arrest is expected to boost the market during the forecast period.
The automated external defibrillator (AED) is a portable electronic device that delivers an electric shock to a person's heart to restore a normal heartbeat during a sudden cardiac arrest. During such emergencies, the AED analyzes the person's heart rhythm and administers an electric shock to restore a regular heartbeat.
The COVID-19 pandemic moderately impacted the automated external defibrillator (AED) market. The pandemic had raised awareness about the importance of emergency preparedness and the need for accessible life-saving devices,including AEDs. This led to an increase in the demand for AEDs in various settings, including healthcare facilities, public spaces, and workplaces. However, the disruption in global supply chains and manufacturing processes of medical devices led to shortages and delays in the production and distribution of AEDs, which slowed the revenue generation of the market to a certain limit.
Automated External Defibrillators Market Dynamics
Major Drivers
Growing prevalence of cardiovascular diseases is expected to drive the market during the forecast period. Surgical procedures for cardiovascular issues often carry the risk of sudden cardiac arrest where the heart's rhythm becomes irregular or stops altogether. In such critical situations, effective life-saving devices, such as automated external defibrillators are used to restore a normal heart rhythm. Thus, the growing number of cardiovascular patients requiring surgical interventions contributes to the market growth.
AEDs are embedded with clear and simple instructions as well as visual and auditory prompts, which guide the defibrillation process. This means that anyone, even bystanders or non-medical personnel,can potentially save a person's life by using an AED in time. Moreover, AEDs significantly improve the chances of survival for individuals experiencing sudden cardiac arrest. Several research has shown that early defibrillation within the first few minutes of cardiac arrest highly increases the likelihood of restoring normal heart rhythm and improving the overall outcome.
-
As per the report published by American Heart Association on January 25, 2023, approximately 928,741 people died in the US in2020, due to cardiovascular diseases (CVDs). Furthermore, one person dies every 34 seconds in the US, due to CVD.
Rising incidence of cardiac arrest is another major driver in the market. Cardiac arrest refers to a sudden and abrupt loss of heart function leading to a cessation of blood circulation. This life-threatening condition happens unexpectedly to individuals of various age groups, including those with pre-existing heart conditions and those without any prior history of heart problems.
AEDs serve as critical devices that help to restore a regular heartbeat by administering an electric shock. The increasing prevalence of cardiac arrest further propels the need for accessible and effective AEDs in various settings, including public spaces, workplaces, schools, and healthcare facilities.
Existing Restraints
High cost of portable and fully automated external defibrillators hinders the market growth. Fully automated external defibrillators are equipped with advanced technologies, which makes them expensive, and not everyone can avail them. Furthermore, AEDs are not suitable for children under 8 years or under a weight of 36 kg, as these devices deliver electric shock between the range of 120-200 joules, which can further damage the child’s heart. All these factors restrain the market to a certain limit.
Emerging Opportunities
Increasing emphasis on technological advancements is expected to create immense opportunities for key players competing in the market in the coming years. Manufacturers are using innovations in medical devices to make them portable as well asenhance user interfaces and connectivity. These features open new avenues for improving AEDs with enhanced functionality.
Scope of the Automated External Defibrillators Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Automated External Defibrillators Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Type (Wearable and Non-Wearable), Technology (Semi-automated External Defibrillators and Fully Automated External Defibrillators), End-user (Hospitals, Public Access Settings, Homecare settings, Pre-hospitals Care & Emergency Medical Service Providers, and Others), and Patient Type (Adults and Children)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Amiitalia; Asahi Kasei Corporation; BIOTRONIK SE & Co. KG; BPL Medical Technologies; CardiAid; CU Medical System Inc.; InstramedIndustria Medica HospitalarLtda; Kestra Medical Technologies, Inc; Koninklijke Philips N.V.; MEDIANA Co., Ltd; Metrax GmbH; NIHON KOHDEN CORPORATION; Progettisrl; SCHILLER AG; Shenzhen Mindray Bio-Medical Electronics Co., Ltd; Stryker; Trivitron Healthcare; Usdefib; and ZOLL Medical Corporation
|
Market Segment Insights
Type Segment Analysis
Based on type,the automated external defibrillators market isbifurcated into wearable and non-wearable. The wearable segment is estimated to hold a major market share during the projection period, due to its continuous monitoring capabilities. Wearable AEDs are lightweight and portable, which allows individuals to carry them anywhere. This enables quick and convenient access to AEDs, making them readily available in case of cardiac emergencies. Furthermore, wearable medical devices are suitable for a wide range of settings, including healthcare environments and out of hospitals.
Technology Segment Analysis
On the basis of technology,the market is classified as semi-automated external defibrillators and fully automated external defibrillators. The fully automated external defibrillators segment is projected to hold a key share of the market during the forecast period, owing to their instant response capabilities, technological advancements, and suitability for untrained individuals to use them. These devices automatically analyze the heart rhythm and deliver defibrillation shocks without any human intervention, which eliminates potential human errors during emergency situations as well as ensures swift and efficient treatment.
The quick response provided by fully automated external defibrillators increases the chances of successful defibrillation and survival during cardiac arrest. The automated shock delivery ensures that the defibrillation process is initiated as quickly as possible, reducing the time between the occurrence of cardiac arrest and the administration of life-saving treatment.
The semi-automated external defibrillators segment is anticipated to grow at a significant pace in the coming years, due to their user-friendly interface, clear instructions, accuracy in rhythm analysis, and widespread usability in various settings. Semi-automated external defibrillatorsprovide clear audio instructions to direct the user to deliver the shock or prompt them to perform cardiopulmonary resuscitation (CPR) if needed. This intuitive interface ensures that even non-medical personnel effectively use the device and provide timely assistance during emergencies.
End-user Segment Analysis
In terms of end-user, the automated external defibrillators market is fragmented into hospitals, public access settings, homecare settings, pre-hospitals care & emergency medical service providers, and others. The hospitals segment is expected to register a robust growth rate during the assessment period,as hospitals serve as vital hubs for handling cardiac emergencies, including sudden cardiac arrest.
AEDs in hospitals are readily accessible and integrated into emergency response protocols. Hospitals often receive patients with known cardiac conditions or those experiencing cardiac emergencies, making AEDs a crucial part of their life-saving equipment. These institutions have specialized cardiac units, intensive care units, and emergency departments where AEDs play a pivotal role in providing immediate intervention and stabilizing patients during cardiac events. Thus, high usage of AEDs in hospitals is expected to propel the segment in the coming years.
The public access settings segment is anticipated to grow at a significant growth rate in the coming years, owing to the increasing focus on public access to AEDs and the implementation of public access defibrillation programs. Public access to AEDs associated with the implementation of public access defibrillation programs provides training to laypersons about CPR and AED usage. These programs aim to empower bystanders to respond effectively during cardiac emergencies and provide immediate defibrillation until professional medical help arrives. The availability of AEDs in public access settings ensures that potential rescuers quickly access these life-saving devices in critical situations. Furthermore, the growing adoption of AEDs in public spaces such as airports, train stations, shopping malls, sports arenas, schools, and community centers boosting the market.
Patient Type Segment Analysis
Based on the patient type, the market is divided into adults and children. The adults segment is expected to expand at a considerable CAGR during the forecast period, due to the highprevalence of cardiac emergencies among adults. Incidences of cardiac arrest are more commonly observed among adults compared to other age groups. The risk of cardiac emergencies, including sudden cardiac arrest, increases with age, as individuals develop underlying cardiovascular conditions or experience age-related changes.
The children segment is anticipated to grow at a rapid pace in the coming years. Sudden cardiac arrest (SCA) in children is caused by various factors such as congenital heart defects, genetic conditions, or underlying medical conditions. These risks and the importance of early defibrillation in children increase the demand for AEDs.
-
As per the Centers for Disease Control and Prevention, nearly 2,000 young people in the US die each year, due to SCA.
Regional Outlook
In terms of region, the global automated external defibrillators market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to the well-established healthcare infrastructure and proactive implementation of public access defibrillation programs. The region has a robust network of hospitals, clinics, and healthcare providers, which ensures the availability and utilization of AEDs in various healthcare settings.
The emphasis on quality healthcare and the integration of AEDs into emergency response protocols contribute to the market expansion in the region.There is widespread acceptance of AEDs in public spaces toprovide immediate assistance during cardiac emergencies. The regional market growth is further attributed to the rising incidence of out-of-hospital cardiac arrest.
-
According to the Centers for Disease Control and Prevention, more than 356,000 people have an out-of-hospital cardiac arrest in the US each year, of which 60% to 80% of them die before reaching the hospital.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the increasing prevalence of cardiovascular diseases and growing public awareness about cardiac health. According to the survey of BioMed Central conducted in 2020, about 550,000 individuals in China experience cardiac arrest every year.
Governments and healthcare authorities in countries such as China, India, Japan, and South Korea are investing in the healthcare sector to improve healthcare facilities, which further supports the enhancement of emergency services and ensures the availability of life-saving devices such as AEDs.
Segments
Type
Technology
- Semi-automated External Defibrillators
- Fully Automated External Defibrillators
End-user
- Hospitals
- Public Access Settings
- Homecare settings
- Pre-hospitals Care and Emergency Medical Service Providers
- Others
Patient Type
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Amiitalia
- Asahi Kasei Corporation
- BIOTRONIK SE & Co. KG
- BPL Medical Technologies
- CardiAid
- CU Medical System Inc.
- InstramedIndustria Medica HospitalarLtda
- Kestra Medical Technologies, Inc
- Koninklijke Philips N.V.
- MEDIANA Co., Ltd
- Metrax GmbH
- NIHON KOHDEN CORPORATION
- Progettisrl
- SCHILLER AG
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- Stryker
- Trivitron Healthcare
- Usdefib
- ZOLL Medical Corporation
Competitive Landscape
Key players competing in the global automated external defibrillators market are Amiitalia; Asahi Kasei Corporation; BIOTRONIK SE & Co. KG; BPL Medical Technologies; CardiAid; CU Medical System Inc.; InstramedIndustria Medica HospitalarLtda; Kestra Medical Technologies, Inc; Koninklijke Philips N.V.; MEDIANA Co., Ltd; Metrax GmbH; NIHON KOHDEN CORPORATION; Progettisrl; SCHILLER AG; Shenzhen Mindray Bio-Medical Electronics Co., Ltd; Stryker; Trivitron Healthcare; Usdefib; and ZOLL Medical Corporation.
These companies are boosting their market share by adopting various strategies such as partnerships, mergers, reduction in production costs, launching new products, and implementing advanced technologies.
-
On August 3, 2021, Kestra Medical Technologies, a global supplier of wearable medical devices and digital healthcare, announced the FDA approval for its new Wearable Cardioverter Defibrillator (WCD) system. This device provides the next generation of monitoring and therapy to protect patients fromthe risk of sudden cardiac deaths (SCD).
Request For Customization
Enquiry Before Buying
Speak With Analyst
